Try our Advanced Search for more refined results
Capital Markets
Capital Markets Law360 provides breaking news and analysis on the capital markets sector. Coverage includes stock and bond offerings, mortgage-backed securities, foreign exchange, follow-on offerings, and debt deals, as well as related litigation and policy developments.
Sign up for a 7-day FREE trial today!
Latest News in Capital Markets
-
June 05, 2025
FINRA Panel Awards More Than $2M Over Mismanaged Stocks
U.S. Capital Wealth Advisors and two representatives must pay more than $2 million and rescind the sale of thousands of shares of Microsoft and Google over claims that they sold off a client's blue-chip investments and told her to invest heavily in an allegedly fraudulent Indian media company, a Financial Industry Regulatory Authority arbitration panel has held.
-
June 05, 2025
Latham-Led Virtual Health Startup Omada Prices $150M IPO
Venture-backed virtual care provider Omada Health Inc. on Thursday priced a $150 million initial public offering within its marketed range, represented by Latham & Watkins LLP and underwriters counsel Davis Polk & Wardwell LLP.
-
June 05, 2025
Crypto.com Says Nevada Can't Sue Over Sports Contracts
The derivatives platform owned by Crypto.com on Thursday urged a Nevada federal judge to block the state's gaming regulators from taking action over its sports event contracts, arguing the federal court has already granted similar relief to trading platform Kalshi.
-
June 05, 2025
SEC Seeks To Cut Enforcement Staff To 2010 Levels
The U.S. Securities and Exchange Commission could see its lowest level of enforcement attorneys since the first Obama administration if Congress approves the agency's requested budget, with the proposal indicating that even more workers could leave the SEC in the next fiscal year.
-
June 05, 2025
Elon Musk Seeks $5B For AI Startup, Amid Other Reports
Elon Musk is planning a $5 billion debt sale for his AI startup, Ontario’s pension seeks final bids for an Indian hospital system, and Merck eyes a Swiss biotech with a potential $3 billion price tag. Here's a rundown of these and other notable deal rumors from the last week.
Areas of Coverage
- TRANSACTIONS
- High-yield debt, corporate bond, convertible debt, and hybrid offerings
- Share buybacks and stock splits
- Stock- or debt-funded acquisitions
- Distressed investments and bankruptcy proceedings
- Joint ventures
- Capital instruments, including mezzanine and venture
- Leveraged buyouts
- Real estate investment trust deals
- AGENCIES
- Financial Industry Regulatory Authority
- U.S. Commodity Futures Trading Commission
- U.S. Department of the Treasury
- Public Company Accounting Oversight Board
- U.S. Securities and Exchange Commission
- European Securities and Markets Authority
- European Central Bank
- European Commission
- UK Financial Conduct Authority
- POLICY & REGULATION
- Dodd-Frank Act
- Delaware corporate law
- Financial company lobbying
- International banking legislation and regulation
- LITIGATION
- Corporate governance cases, including those over leadership changes, executive compensation, and shareholder rights
- Competition disputes
- Privacy issues
- PROFILES
- Personnel moves
- Profiles of capital markets practices
Readership
- Capital markets lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Executives and attorneys in the capital markets industry
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals